6 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of 4-chloro-3-(5-(pyridin-3-yl)-1,2,4-oxadiazole-3-yl)benzamides as novel RET kinase inhibitors.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Ocean University of China
Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
University of Arkansas For Medical Sciences
Antitarget Selectivity and Tolerability of Novel Pyrrolo[2,3-![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
The Genomics Institute of The Novartis Research Foundation
Discovery of 4-methyl-N-(4-((4-methylpiperazin- 1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-oxy)benzamide as a potent inhibitor of RET and its gatekeeper mutant.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Xiamen University
Efficacy and Tolerability of Pyrazolo[1,5-![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
The Genomics Institute of The Novartis Research Foundation